Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
33 hedge funds and large institutions have $2.87M invested in Pernix Therapeutics Holdings, Inc. in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
14% more funds holding
Funds holding: 29 → 33 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less capital invested
Capital invested by funds: $5.05M → $2.87M (-$2.17M)
66% less call options, than puts
Call options by funds: $29K | Put options by funds: $85K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$1.1M |
| 2 |
Renaissance Technologies
New York
|
+$193K |
| 3 |
VF
Virtu Financial
New York
|
+$113K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$88.5K |
| 5 |
LCC
Lincoln Capital Corp
East Greenwich,
Rhode Island
|
+$28.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$36K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20.1K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$6.44K |
| 4 |
Morgan Stanley
New York
|
-$2.08K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$1.78K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$22 | +13 | +6% |
|
27
Bank of America
Charlotte,
North Carolina
| – | +$350 | +209 | +1,900% |
|
PTX Hedge Fund Activity: Q3 2018 in Review
33 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2018, worth a combined $2.87M — down 43% from $5.05M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PTX positions and 4 closed out — a net gain of 4 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $1.1M. The largest seller was Goldman Sachs, exiting entirely with an estimated $36K sold.
- 33 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2018, up from 29 in Q2 2018.
- Funds reported $2.87M of Pernix Therapeutics Holdings, Inc. stock for Q3 2018, down 43% quarter-over-quarter.
- 8 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2018 and 4 closed out, a net change of +4 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2018 was Deerfield Management, an estimated $1.1M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2018 was Goldman Sachs, an estimated $36K sold.
Based on aggregated 13F filings for Q3 2018.